BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24722381)

  • 41. The male HPV vaccine.
    O'Connor MB
    Ir Med J; 2009; 102(10):345. PubMed ID: 20108812
    [No Abstract]   [Full Text] [Related]  

  • 42. Epidemiology of malignant degeneration of condylomata acuminata in Uganda.
    Schmauz R; Owor R
    Pathol Res Pract; 1980 Dec; 170(1-3):91-103. PubMed ID: 18788155
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiological characteristics of genital herpes and condyloma acuminata in patients presenting to urologic and gynecologic clinics in Korea.
    Lee CB; Choe HS; Hwang SJ; Lee SJ; Cho YH
    J Infect Chemother; 2011 Jun; 17(3):351-7. PubMed ID: 20839024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence, psychosocial burden, and economic impact of genital warts in Mexico.
    Domenech-Viñolas M; León-Maldonado L; Ramírez-Palacios P; Flores YN; Granados-García V; Brown B; Corona E; Liu S; Lazcano-Ponce E; Salmerón J
    Salud Publica Mex; 2018; 60(6):624-632. PubMed ID: 30699267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The incidence of genital warts in Australian women prior to the national vaccination program.
    Brotherton JM; Heywood A; Heley S
    Sex Health; 2009 Sep; 6(3):178-84. PubMed ID: 19653953
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Epidemiologic analysis of genital diseases associated to papillomavirus].
    Rios AC; Cavalcanti SM; Menezes DM; Oliveira LH
    Rev Assoc Med Bras (1992); 1995; 41(5):333-6. PubMed ID: 8731597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and subclinical condyloma. Rates among male sexual partners of women with genital human papillomavirus infection.
    Maymon R; Bekerman A; Werchow M; Maymon BB; Segal R; Faktor JH
    J Reprod Med; 1995 Jan; 40(1):31-6. PubMed ID: 7722972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparative epidemiologic study of 120 patients with condylomatous lesions and 120 control patients].
    Beuret T; Sadoul G; Fari A; Ionesco M; de Brux J
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(5):555-64. PubMed ID: 3668181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changing clinical expression of Behçet disease in Korea during three decades (1983-2012): chronological analysis of 3674 hospital-based patients.
    Kim DY; Choi MJ; Cho S; Kim DW; Bang D
    Br J Dermatol; 2014 Feb; 170(2):458-61. PubMed ID: 24117362
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Anogenital condylomata in the children. Practice guidelines for a medical expertise].
    Vanhooteghem O; Müller G; de la Brassinne M
    Rev Med Liege; 2007 Mar; 62(3):151-4. PubMed ID: 17511382
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services.
    Oliphant J; Perkins N
    N Z Med J; 2011 Jul; 124(1339):51-8. PubMed ID: 21952330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genital warts in men: a large population-based cross-sectional survey of Danish men.
    Munk C; Nielsen A; Liaw KL; Kjaer SK
    Sex Transm Infect; 2012 Dec; 88(8):640-4. PubMed ID: 22941865
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increase of genital human papillomavirus infection among men and women in Croatia.
    Grce M; Magdić L; Kocijan I; Pavelić K
    Anticancer Res; 1996; 16(2):1039-41. PubMed ID: 8687096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV).
    Aubin F; Prétet JL; Jacquard AC; Saunier M; Carcopino X; Jaroud F; Pradat P; Soubeyrand B; Leocmach Y; Mougin C; Riethmuller D;
    Clin Infect Dis; 2008 Sep; 47(5):610-5. PubMed ID: 18637758
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human papillomavirus, genital warts, and vaccines.
    Hsueh PR
    J Microbiol Immunol Infect; 2009 Apr; 42(2):101-6. PubMed ID: 19597640
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Start early to prevent genital HPV infection-and cervical cancer.
    Heavey E
    Nursing; 2008 May; 38(5):62-3. PubMed ID: 18431214
    [No Abstract]   [Full Text] [Related]  

  • 57. Dipyridamole, as an interferon inducer, versus placebo in the prevention of recurrences of condylomata acuminata after diathermocoagulation.
    Mancuso G; Reggiani M; Berdondini RM; Errani A
    Genitourin Med; 1995 Feb; 71(1):57-8. PubMed ID: 7750961
    [No Abstract]   [Full Text] [Related]  

  • 58. [Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population of Amsterdam. Il Over 90% participation and almost 5% prevalence].
    van den Hoek JA; Mulder-Folkerts DK; Coutinho RA; Dukers NH; Buimer M; van Doornum GJ
    Ned Tijdschr Geneeskd; 1999 Mar; 143(13):668-72. PubMed ID: 10321299
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of human papilloma virus genital infections in sexually transmitted diseases clinic attendees in Ibadan.
    Okesola AO; Fawole OI
    West Afr J Med; 2000; 19(3):195-9. PubMed ID: 11126083
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genital warts and chlamydia in Australian women: comparison of national population-based surveys in 2001 and 2011.
    Liu B; Donovan B; Brotherton JM; Saville M; Kaldor JM
    Sex Transm Infect; 2014 Nov; 90(7):532-7. PubMed ID: 24570485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.